Loading...

ACAD ACADIA PHARMACEUTICALS INC Management Changes 8-K Filing

CD P

CD

ACADIA PHARMACEUTICALS INC

(ACAD)

2024 8-K

Summary

Summary

Financial Statements

Management Changes

Earnings Releases

Bylaw Amendments

Financial Results

Management Change

Q3 Financial Results

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Results of Phase 3 ADVANCE-...

Financial Results Announcement

Departure of Directors

Management Change

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

External Links:

ACADIA Pharmaceuticals announced the termination of CEO Stephen R. Davis and appointed Catherine Owen Adams as the new CEO, with Davis receiving severance benefits including 1.5 times his salary and a pro-rata bonus, while Adams will have a $900,000 salary and a $500,000 sign-on bonus.

AI Assistant

ACADIA PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.